Jean-Francois Hubert Delagneau

Title: The Innovations of Jean-Francois Hubert Delagneau

Introduction

Jean-Francois Hubert Delagneau is a notable inventor based in La Celle Saint Cloud, France. He has made significant contributions to the field of synthetic peptides, particularly in the context of biological assays for detecting infections caused by group O HIV-1 viruses. With a total of 2 patents, Delagneau's work is recognized for its potential impact on medical diagnostics.

Latest Patents

Delagneau's latest patents focus on synthetic peptides that are useful in biological assays. These peptides are of the monomer type, consisting of 13 to 33 amino acids, and can exist in either linear form or cyclized form through inter-cysteine disulphide bridges. The general formula for these synthetic peptides includes various radicals and peptide sequences that enhance their functionality in detecting HIV-1 infections.

Career Highlights

Delagneau is associated with Bio-Rad Pasteur, a company known for its advancements in biotechnology and diagnostics. His work at Bio-Rad Pasteur has allowed him to collaborate with other experts in the field, furthering the development of innovative solutions for health-related challenges.

Collaborations

Some of Delagneau's notable coworkers include Stephane Jean Xavier Gadelle and Denis Marie Bernárd Chenebaux. Their collective expertise contributes to the ongoing research and development efforts within their organization.

Conclusion

Jean-Francois Hubert Delagneau's contributions to the field of synthetic peptides and his innovative patents highlight his role as a significant inventor in the medical diagnostics arena. His work continues to pave the way for advancements in detecting infections, showcasing the importance of innovation in healthcare.